Pune, India, Jan. 25, 2021 (GLOBE NEWSWIRE) -- The increasing prevalence of chronic diseases is expected to fuel demand for digital therapeutics during the forecast period, states Fortune Business Insights, in a report, titled “Digital Therapeutics Market Size, Share & Industry Analysis, By Application (Diabetes, Weight Management, Cardiovascular Diseases, Respiratory Diseases, Others), By Product (Software, Devices), By End-user (Patients, Caregivers) and Regional Forecast 2020-2027.” The market size is likely to proliferate owing to the growing geriatric population.

Notable Development:

    ·November 2019: Welldoc and Astellas Pharma Inc. developed and commercialized the Bluestar product in Japan and Asia.


Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/digital-therapeutics-market-103501


Surging Cases of Cardiovascular Diseases to Bolster Growth

The increasing cases of heart strokes can improve the prospects of the market in the forthcoming years. As per the data reported by the American Heart Association’s Heart and Stroke Statistics – 2019, nearly half of (48%, 121.5 million in 2016) of all adults in the United States suffered from some type of cardiovascular disease. The growing emphasis on early diagnosis, disease prevention, and patient convenience can spur lucrative opportunities for the market.

Moreover, the increasing prevalence of chronic diseases owing to lack of physical exercise, sedentary lifestyles, and increased consumption of junk food can favor the market growth in the forthcoming years. The surging healthcare development and growing technological advancements are expected to contribute positively to the market's growth.

The occurrence of coronavirus has caused enormous damage to various businesses across the world. We understand that this health emergency has negatively impacted various sectors across the globe. Rising support from governments and several companies can help in the fight against this highly infectious virus. There are some industries that are struggling, and some are thriving. More or less, nearly every sector is estimated to be impacted by this pandemic.

We are perpetually working on our reports to help uplift businesses in this crucial time. Our expertise and experience can offer enormous benefits to help regain during this global pandemic. 


Click here to get the short-term and long-term impact of COVID-19 on this market.


Digital therapeutic delivers authentic therapeutic interventions to patients and offers high-quality software programs to inhibit, accomplish, or treat a medical disease or disorder.

However, lack of awareness and hesitancy among patients to adopt digital therapeutics are factors expected to hamper the market's growth.  Besides, data privacy concerns are expected to further hinder the market's growth in the forthcoming years.

Favorable Government Initiatives to Push Growth in North America

North America is expected to hold the largest share globally due to the increasing prevalence of chronic diseases. The favorable government initiatives in the U.S. are expected to contribute positively to the region's market growth. The refining compensation structure for digital therapeutic solutions and accumulative investment in the digital therapeutics field is expected to boost North America's development. 

Asia Pacific is expected to expand radically during the forecast period owing to the increasing prevalence of chronic illness. Moreover, the growing geriatric population and expansion of digital therapeutics can further uplift the region's market.


Quick Buy -  Digital Therapeutics Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/103501


The Major Companies in The Global Digital Therapeutics Include:


Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/digital-therapeutics-market-103501


Global Digital Therapeutics Segmentation:

By Application     

•              Diabetes

•              Weight Management

•              Cardiovascular Diseases

•              Respiratory Diseases

•              Others

By Product           

•              Software

•              Devices

By End-user          

•              Patients

•              Caregivers

By Geography      

•              North America (USA, Canada)

•              Europe (UK, Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)

•              Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)

•              Latin America (Brazil, Mexico, Rest of Latin America)

•              Middle East & Africa (South Africa, GCC, and Rest of Middle East & Africa)


Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/digital-therapeutics-market-103501


SECONDARY RESEARCH IS CONDUCTED TO DERIVE THE FOLLOWING INFORMATION:


Have a Look at Related Reports:

Europe Urinary Drainage Bags Market Share & Industry Analysis, By Product (Leg Bags and Large Capacity Bags), By Capacity (0-500 ml, 500-1000 ml, 1000-2000 ml, and more than 2000 ml), By Number of Chambers (Single Chamber, 2 Chamber, 3 Chamber), End-user (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care, and Others) and Regional Forecast, 2019-2026

Europe Urinary Catheters Market Share & Industry Analysis, By Product (Indwelling Catheters, Intermittent Catheters, External Catheters), By Application (Urinary Incontinence, Benign Prostatic Hyperplasia, Surgery, Others), By Gender (Female, Male), By End User (Hospitals, Age Care Centers, Others) and Regional Forecast, 2019-2026

In-vitro Diagnostics (IVD) Market Share & Industry Analysis, By Product Type (Instruments, Reagents & Consumables), By Technique (Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Point of Care, Hematology and Others), By Application (Infectious Diseases, Cardiology, Oncology, Gastroenterology, Others), By End User (Clinical Laboratories, Hospitals, Physicians Offices, Others) and Regional Forecast, 2019 – 2026

Hepatitis C Drug Market Share & Industry Analysis, By Product (NS5A Inhibitor (Protease Inhibitors), Fixed-dose Combination, Others), By Disease Type (Acute Hepatitis C, Chronic Hepatitis C), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026

Schizophrenia Drugs Market Share & Industry Analysis, By Therapeutic Class (Second Generation, Third Generation, Others), By Treatment (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others) and Regional Forecast, 2019-2026


About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.


Contact Us:

Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs